Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v2.3.0.15
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Operating activities:    
Net income $ 22,085 $ 18,498
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization of bank premises and equipment 5,005 4,846
Other-than-temporary impairment recognized in earnings 400  
Amortization, net 5,300 4,885
Provision for loan losses 14,400 14,868
Decrease (increase) in loans held for sale, net 12,188 (30,101)
(Gains) losses on the sale of investment securities (483) (62)
Losses (gains) on sales of other real estate owned and premises, net 972 (376)
Stock-based compensation expense 467 567
Decrease in other assets 4,263 1,021
Increase in other liabilities 11,048 3,874
Net cash and cash equivalents provided by operating activities 75,645 18,020
Investing activities:    
Purchases of securities available for sale (130,160) (141,868)
Proceeds from sales of securities available for sale 18,365 106,549
Proceeds from maturities, calls and paydowns of securities available for sale 87,585 85,153
Net decrease (increase) in loans 69,306 (6,427)
Sales of bank premises and equipment and OREO, net 6,815 6,986
Cash paid in branch acquisition (26,437)  
Cash received in acquisitions 230 137,460
Net cash and cash equivalents provided by investing activities 25,704 187,853
Financing activities:    
Net increase in noninterest-bearing deposits 53,459 30,440
Net decrease in interest-bearing deposits (37,511) (80,932)
Net decrease in short-term borrowings (22,517) (114,858)
Net (increase) decrease in long-term borrowings 366 (925)
Cash dividends paid-common stock (5,460) (4,667)
Cash dividends paid-preferred stock (1,386) (997)
Tax benefit from the exercise of equity-based awards 1 3
Proceeds from the issuance of common stock 323 290
Net cash and cash equivalents used in financing activities (12,725) (171,646)
Increase in cash and cash equivalents 88,624 34,227
Cash and cash equivalents at beginning of the period 61,153 45,911
Cash and cash equivalents at end of the period 149,777 80,138
Supplemental Disclosure of Cash Flow Information    
Interest 25,265 28,291
Income taxes 4,238 8,672
Supplemental Schedule of Noncash Activities    
Unrealized gains on securities available for sale 15,834 11,569
Unrealized loss on cash flow hedge (2,826) (2,858)
Transfer of loans to other real estate owned, net 9,236 11,851
Transactions related to acquisitions    
Loans 70,817 981,541
Securities   218,676
Other assets 4,324 78,542
Noninterest bearing deposits 4,366 171,117
Interest bearing deposits 44,503 1,037,206
Borrowings   75,789
Other liabilities 65 1,832
Common Stock [Member]
    
Supplemental Schedule of Noncash Activities    
Stock issued for acquisition   96,083
Preferred Stock [Member]
    
Supplemental Schedule of Noncash Activities    
Stock issued for acquisition   $ 34,192